Analyst Activity – Canaccord Genuity Reiterates Buy on ANI Pharmaceuticals (NASDAQ:ANIP)

Analyst Ratings For ANI Pharmaceuticals (NASDAQ:ANIP)

Story continues below

Today, Canaccord Genuity reiterated its Buy rating on ANI Pharmaceuticals (NASDAQ:ANIP) with a price target of $66.00.

There are 1 hold rating, 2 buy ratings on the stock.

The current consensus rating on ANI Pharmaceuticals (NASDAQ:ANIP) is Buy (Score: 2.67) with a consensus target price of $67.33 per share, a potential 17.12% upside.

Some recent analyst ratings include

  • 10/16/2017-Canaccord Genuity Reiterated Rating of Buy .
  • 7/4/2017-Guggenheim Reiterated Rating of Buy.
  • 7/19/2016-Citigroup Inc. Upgrade from a “Outperform” rating to a “” rating.
  • 6/22/2016-Raymond James Financial, Inc. initiated coverage with a Strong-Buy rating.
  • 5/24/2016-Standpoint Research was Downgraded by analysts at Standpoint Research from a “Buy ” rating to a ” Hold” rating.

Recent Insider Trading Activity For ANI Pharmaceuticals (NASDAQ:ANIP)
ANI Pharmaceuticals (NASDAQ:ANIP) has insider ownership of 31.80% and institutional ownership of 55.81%.

  • On 8/22/2016 Arthur Przybyl, Insider, sold 37,455 with an average share price of $66.97 per share and the total transaction amounting to $2,508,361.35. View SEC Filing
  • On 8/8/2016 Robert W Schrepfer, VP, sold 12,500 with an average share price of $67.06 per share and the total transaction amounting to $838,250.00. View SEC Filing
  • On 12/18/2015 James G Marken, VP, sold 3,500 with an average share price of $43.26 per share and the total transaction amounting to $151,410.00. View SEC Filing
  • On 11/12/2015 Arthur Przybyl, CEO, bought 2,500 with an average share price of $40.95 per share and the total transaction amounting to $102,375.00. View SEC Filing
  • On 3/19/2015 James G Marken, VP, sold 15,000 with an average share price of $66.50 per share and the total transaction amounting to $997,500.00. View SEC Filing
  • On 9/15/2014 Ross J Mangano, Director, bought 3,000 with an average share price of $27.49 per share and the total transaction amounting to $82,470.00. View SEC Filing
  • On 9/9/2014 Arthur Przybyl, CEO, bought 1,000 with an average share price of $26.50 per share and the total transaction amounting to $26,500.00. View SEC Filing

Recent Trading Activity for ANI Pharmaceuticals (NASDAQ:ANIP)
Shares of ANI Pharmaceuticals closed the previous trading session at with shares trading hands.

An ad to help with our costs